These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1067029)

  • 1. LP-X test in sarcoidosis patients with liver involvement: comparison with other liver function tests.
    Lebacq EG; Heller F
    Ann N Y Acad Sci; 1976; 278():439-44. PubMed ID: 1067029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-X (LP-X) in liver disease.
    Ritland S; Blomhoff JP; Elgjo K; Gjone E
    Scand J Gastroenterol; 1973; 8(2):155-60. PubMed ID: 4697077
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipoprotein-X and diagnosis of cholestasis: comparison with other biochemical parameters and liver biopsy.
    Fellin R; Manzato E; Zotti S; Baggio G; Briani G; Rugge M
    Clin Chim Acta; 1978 Apr; 85(1):41-7. PubMed ID: 25728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small bile duct abnormalities in sarcoidosis.
    Murphy JR; Sjogren MH; Kikendall JW; Peura DA; Goodman Z
    J Clin Gastroenterol; 1990 Oct; 12(5):555-61. PubMed ID: 2229999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.
    Milewski B; Palynyczko Z
    Pol Med Sci Hist Bull (1973); 1975; 15(5-6):551-5. PubMed ID: 1228704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-test abnormalities in sarcoidosis.
    Cremers J; Drent M; Driessen A; Nieman F; Wijnen P; Baughman R; Koek G
    Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):17-24. PubMed ID: 22008629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The liver in sarcoidosis.
    Lehmuskallio E; Hannuksela M; Halme H
    Acta Med Scand; 1977; 202(4):289-93. PubMed ID: 920248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The lipoprotein X-test. Pointing out abnormal lipoprotein in cholestasis].
    Ritland S
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1155-6. PubMed ID: 4751603
    [No Abstract]   [Full Text] [Related]  

  • 11. Stone or stricture as a cause of extrahepatic cholestasis--do liver function tests predict the diagnosis?
    Karvonen J; Kairisto V; Grönroos JM
    Clin Chem Lab Med; 2006; 44(12):1453-6. PubMed ID: 17163822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of the liver function test in differential diagnosis of infantile hepatitis syndrome and biliary atresia].
    Chu B; Jiang LR; Zhou S; Xu YZ; Zhang B; Deng ZH
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):953-6. PubMed ID: 20113595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)].
    Lachmann D
    Wien Klin Wochenschr Suppl; 1977; 69():3-28. PubMed ID: 266315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein X in hepatobiliary diseases].
    Mordasini RC; Berthold S; Schlumpf E; Keller H; Riva G
    Schweiz Med Wochenschr; 1975 Jul; 105(27):863-72. PubMed ID: 2969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatobiliary disease in sarcoidosis.
    Kahi CJ; Saxena R; Temkit M; Canlas K; Roberts S; Knox K; Wilkes D; Kwo PY
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Jun; 23(2):117-23. PubMed ID: 17937107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases.
    Magnani HN; Alaupovic P
    Gastroenterology; 1976 Jul; 71(1):87-93. PubMed ID: 179911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976-2013.
    Ungprasert P; Crowson CS; Simonetto DA; Matteson EL
    Am J Gastroenterol; 2017 Oct; 112(10):1556-1563. PubMed ID: 28872150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LP-X in the first month of life (author's transl)].
    Lachmann D; Eder G
    Padiatr Padol; 1977; 12(4):334-8. PubMed ID: 904943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein X and alkaline phosphatase as indicators of cholestasis.
    Gerson B; Menduke H; Boitnott JK; Maddrey WC; Ireland JE; Rock RC
    Johns Hopkins Med J; 1979 Feb; 144(2):41-4. PubMed ID: 216843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benign recurring intrahepatic cholestasis--a case report].
    Stremmel W; Scholten T; Miller B; Strohmeyer G
    Z Gastroenterol; 1984 Jun; 22(6):300-4. PubMed ID: 6464522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.